inactive vs. HCs: 69.06% ± 11.39% vs.77.38% ± 10.53%, p = .014) (Figure 3B), but also the proportion of CD161+CD56+ NK cells in active pSS patients significantly decreased compared with inactive pSS patients (55.04% ± 18.73% vs. 69.06% ± 11.39%, p = .016) (Figure 3B). The gene discussed is NCAM1; the disease is peeling skin syndrome.